IntraBiotics, Allos price IPOs

IBPI, which is developing antibacterial and antifungal therapeutics, raised $112.5 million through the sale of 7.5 million shares at $15 per share, which was the top of the company's proposed price range. The IPO, which values the company at $428.7 million, was underwritten by Deutsche Banc Alex. Brown; Warburg Dillon Read; SG Cowen; and Adams Harkness Hill. ...